ASD Healthcare's Cubixx system transmits its 400-billionth RFID scan
Vendor-managed system inventories and protects specialty pharmaceuticals in healthcare settings
Drug deliveries by drone--why not?
DHL garners headlines with a 'parcelcopter' delivering daily drugs to remote North Sea island
Simplified approaches to temperature-controlled clinical trial packaging
Often, needless cost and complexity--without improving quality and safety--impede cold chain packaging planning
HHS OIG looks deeply into copay cards for Medicare beneficiaries, finds potential kickback violations
Pharma companies will need to do more than rely on pharmacies' adjudication of claims
A brightening outlook for pharma
Integrichain updates its channel-data information services for mobile access
More engagement with pharma financial, marketing and supply-chain teams calls for easier access, says the company
Reverse logistics processor is indicted by DoJ for fraud and theft
Feds allege that Guaranteed Returns improperly withheld over $116 million in reimbursements from drug purchasers
Look to 'Third Sector' drugs for faster market growth, says IMS Health
New study identifies a category between branded and generic
The Impending AMP Rule, still waiting three years later
Some state-level changes give an indication of what to prepare for
Economic and clinical value: the future of cancer care
An 'expectations convergence' is building in how drug efficacy aligns with patient outcomes
The potential for outcomes-based contracting
Contracts with payers that contain terms based on outcomes can highlight a drug's value
The next generation of MDM
Clinical trial logistics capabilities are expanding
Service providers are building out a wider range of services to meet drug developers' needs
Outsourcing to innovate: the reinvention of pharma contract services
More complex products and higher risk are changing the nature of pharmaceutical outsourcing
A conversation with Homi Kapadia, Deloitte Life Sciences
The maturing rare-disease market
As rare diseases have emerged as a market opportunity for pharma over the past several years, industry practices are beginning to stabilize
SAFE-BioPharma opens competition for 'Digi' digital-identity award
Nonprofit seeks to raise profile of the value of industry-wide identity-authentication standards
Physician-employees want better communication with pharma--and with their own management
No-see policies leave many physicians in the dark about formularies and medication benefits
Dohmen Life Science sharpens its focus on specialty pharma/device services
Self-styled '156-year-old startup' aims to attract small-to-medium companies with outsourced commercialization services
'Primary medication non-adherence'--a new measure for prescription abandonment
The pervasiveness of e-prescribing allows for better analysis of adherence, says NEHI
Early views at what a US biosimilars market might look like
HDMA's research arm studies biosimilar market dynamics
More relief shipments to Ebola-wracked Africa
Cardinal Health works with Americares, and McKesson with World Vision, to deliver supplies
Cold Chain Forum showcases new products, services
Tracking systems dominate product introductions
Diplomat Pharmacy has a successful IPO, garnering $173 million
Largest independent specialty pharmacy rides specialty-pharma wave
AmerisourceBergen's ThinkLive manufacturer summit highlights an international push
Efforts to align drug wholesaling business with manufacturer services
Drug delivery vendor pairs up with 'gamification' software for patient adherence
West Pharma's electronic autoinjectors will connect with HealthPrize software
Omnicare Specialty expands its offices; scores another client
Company is part of limited distribution for a Lundbeck neurologic treatment
CMS' Open Payments site goes live--pharma industry, healthcare professions survive
Muted reaction to revelations of the Physician's Sunshine Act
Cardinal Health Specialty adds molecular diagnostics to its oncology support services
Agreement with KEW Group brings genetic screening and a pathway program
Biosimilars scorecard: 700 products in development; 245 developers
Thomson Reuters Bioworld report tracks biosimilar development
